Biotech Acquisition Company Cl A (BIOT)
Biotech Acquisition Company Cl A (BIOT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2021 | 12-2020 | 12-2006 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | 91 | N/A | N/A |
| TOTAL | $300 | $N/A | $N/A |
| Non-Current Assets | |||
| Investments And Advances | 230,021 | 0 | 0 |
| Other Non-Current Assets | 0 | 90 | 0 |
| TOTAL | $230,021 | $90 | $N/A |
| Total Assets | $230,321 | $90 | $N/A |
| Liabilities | |||
| Current Liabilities | |||
| Accrued Expenses | 313 | N/A | N/A |
| Other current liabilities | 1 | N/A | N/A |
| TOTAL | $314 | $70 | $N/A |
| Non-Current Liabilities | |||
| Other Non-Current Liabilities | 257,177 | 0 | 0 |
| TOTAL | $257,177 | $N/A | $N/A |
| Total Liabilities | $257,490 | $70 | $N/A |
| Shareholders' Equity | |||
| Shares Outstanding, K | 28,750 | 28,750 | N/A |
| Common Shares | 1 | 1 | N/A |
| Retained earnings | -27,170 | -5 | N/A |
| TOTAL | $-27,170 | $20 | $N/A |
| Total Liabilities And Equity | $230,321 | $90 | $0 |